Cancer Today Executive Editor Kevin McLaughlin and Editor Marci A. Landsmann report on the Scientist↔Survivor Program and other news from the AACR Annual Meeting 2014 in San Diego.
New therapies enable immune cells to attack and destroy cancer. Researchers have high hopes for their role in cancer treatment.
Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!
Amgen is a supporter of Cancer Today.